Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line
Given that retatrutide is not currently licensed in the UK, any access to this compound outside of a clinical trial would be through unlicensed or unregulated channels, carrying both legal implications and significant safety risks
Diet, Lifestyle, and Environmental Influences Glutathione levels depend heavily on diet, lifestyle, and environmental factors
Currently, many GLP-1RAs have already been approved for the treatment of diabetes and obesity and could be repurposed for the treatment of pain symptoms
Retatrutide has not yet received marketing authorisation from the MHRA or the EMA, and therefore no official UK or European prescribing guidelines currently exist for this agent